COMMUNIQUÉS West-GlobeNewswire

Summit Therapeutics to Participate in Upcoming Investor Conferences
22/11/2017
Summit Therapeutics plc ("Summit", or the "Company") SUMMIT THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES Oxford, UK, 22 November 2017- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug [...]
Preferred Dental Technologies Announces 3D Technology Breakthrough that brings its Game Changing Technology to the Forefront
22/11/2017
WINNIPEG, Manitoba, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Preferred Dental Technologies Inc. ( “ Company ”) (CSE:PDT) announces 3D Technology Breakthrough that brings its game changing technology to the forefront. The [...]
GW Pharmaceuticals to Present at Upcoming Investor Conferences
22/11/2017
– 29th Annual Piper Jaffray Healthcare Conference on November 29, 2017 – – Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference on November 30, 2017 – LONDON, Nov. 22, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals [...]
REGENXBIO to Present at Upcoming Investor Conferences
22/11/2017
ROCKVILLE, Md., Nov. 22, 2017 (GLOBE NEWSWIRE) -- REGENXBIO Inc. (Nasdaq: RGNX ), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its [...]
Summit Therapeutics to Participate in Upcoming Investor Conferences
22/11/2017
OXFORD, United Kingdom, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and [...]
Evogene Reports Third Quarter 2017 Financial Results
22/11/2017
REHOVOT, Israel, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN ) (TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a unique computational [...]
Pluristem Granted Key U.S. Patent for Skeletal Muscle Regeneration - a Meaningful Asset Ahead of Upcoming Phase III Femoral Neck Fracture Study
22/11/2017
Patent relates to the use of Mesenchymal Stem Cells (MSCs) for muscle regeneration following muscle injury Pivotal Phase III study to take place in U.S. and Europe to support recovery from hip fracture HAIFA, Israel, [...]
Avivagen Announces the Appointment of Mr. Aubrey Dan to the Board of Directors
22/11/2017
OTTAWA, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a life sciences innovation company with a series of patent protected products that support and optimize [...]
RadNet, Inc. to Present at the Bank of America Merrill Lynch 2017 Leveraged Finance Conference on November 29, 2017
22/11/2017
LOS ANGELES, Nov. 22, 2017 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
Gemphire to Present at the Piper Jaffray and LD Micro Investor Conferences
22/11/2017
LIVONIA, Mich., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
22/11/2017
COPENHAGEN, Denmark, November 22, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company's share capital has been increased by nominally DKK 2,637,500 as a consequence of employees' exercise [...]
AroCell AB (publ) signs Letter of Intent with Korean-based company, Green Cross Cell Corporation.
22/11/2017
AroCell AB (publ) signs Letter of Intent with Korean-based company, Green Cross Cell Corporation. The companies have agreed to enter into a collaboration for the clinical development of TK 210 ELISA as a complementary [...]
AroCell AB: Reporting period 1 July - 30 September 2017
22/11/2017
AroCell AB (publ) Reporting period 1 July - 30 September 2017 Net sales were 0 (46) KSEK Losses after financial items were - 3,678 (- 2,590) KSEK Earnings per share were - 0.12 (- 0.09) SEK Cash flow from operating [...]
NEOVACS ANNONCE L'ATTRIBUTION GRATUITE DE BONS DE SOUSCRIPTION D'ACTIONS REMBOURSABLES AU BENEFICE DES ACTIONNAIRES DE LA SOCIETE ET UNE ÉMISSION OBLIGATAIRE CONVERTIBLE D'UN MONTANT DE 5,15 M€
22/11/2017
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NEOVACS ANNONCE L'ATTRIBUTION GRATUITE DE BONS DE SOUSCRIPTION D'ACTIONS REMBOURSABLES (BSAR) AU BENEFICE DES ACTIONNAIRES DE LA SOCIETE ET LE [...]
Portola Pharmaceuticals Provides Update on Bevyxxa® (betrixaban) Commercial Launch
22/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the [...]
Prima Secures European Patent Grant for Lead Product IMP321 in Cancer
22/11/2017
SYDNEY, Australia, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX:PRR) (NASDAQ: PBMD ) (“Prima”, the “Company”) announces the grant of patent number 2604275 entitled “Use of Recombinant LAG-3 or the Derivatives [...]
Synergy CHC Corp. Announces Third Quarter 2017 Results
21/11/2017
Westbrook, Maine, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, reported results for the quarter ended September 30, 2017. [...]
Celyad to Present at the 29th Annual Piper Jaffray Healthcare Conference
21/11/2017
MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Euronext Paris:CYAD) (NASDAQ: CYAD ), a pioneer in the discovery and development of CAR-T cell therapies, today announced [...]
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference
21/11/2017
ROCKVILLE, Md., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq: SCMP ), a global biopharmaceutical company, today announced that it will participate in a fireside chat at the 29 th [...]

Pages